Poor health-related quality of life and abnormal psychosocial adjustment in Italian children with perinatal HIV infection receiving highly active antiretroviral treatment

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 22, Issue 7, 2010, Pages 858-865

  Bomba, Monica ^a   Nacinovich, Renata ^b   Oggiano, Silvia ^b   Cassani, Morena ^a   Baushi, Liliana ^a   Bertulli, Cristina ^a,c   Longhi, Daniela ^d   Coppini, Simonetta ^d   Parrinello, Giovanni ^a   Plebani, Alessandro ^a,c   Badolato, Raffaele ^a,c  

^a UNIVERSITY OF BRESCIA   (Italy)

^b SAN GERARDO HOSPITAL   (Italy)

^c UNIVERSITY OF BRESCIA   (Italy)

^d Associazione Essere Bambino   (Italy)

Author keywords

children; health related quality of life; HIV

Indexed keywords

ANTIRETROVIRUS AGENT; VIRUS RNA;

ACADEMIC ACHIEVEMENT; ADOLESCENT; ADULT; ARTICLE; BEHAVIOR DISORDER; CHILD; CHILD BEHAVIOR CHECKLIST; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DELINQUENCY; FEMALE; FUNCTIONAL ASSESSMENT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ITALY; MALE; MORBIDITY; PERINATAL INFECTION; PRESCHOOL CHILD; PRIORITY JOURNAL; QUALITY OF LIFE; SCHOOL CHILD; SOCIAL COMPETENCE; SOCIAL PSYCHOLOGY; SOCIAL STATUS; SURVIVAL TIME;

ADAPTATION, PSYCHOLOGICAL; ADOLESCENT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHILD; CHILD BEHAVIOR DISORDERS; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH STATUS; HIV INFECTIONS; HUMANS; ITALY; MALE; QUALITY OF LIFE; QUESTIONNAIRES; SOCIAL BEHAVIOR DISORDERS;

EID: 77954718401     PISSN: 09540121     EISSN: 13600451     Source Type: Journal    
DOI: 10.1080/09540120903483018     Document Type: Article

References (26)

1. Achenbach, T.M. (1991). Manual for the Child Behavior Checklist/4-18. Burlington, VT: University of Vermont.
2. Achenbach, T.M. (2001). Child Behavior Checklist/4-18. Bosisio Parini: Editore Ghedini Libraio.
3. Badolato, R., Schumacher, R.F., Rodella, E., Gargiulo, F., Torti, C., Notarangelo, L.D., et al. (2005). Genotyping for guiding drug choice in human immunodeficiency virus-infected children failing multiple antiretroviral treatment regimens. Pediatric Infectious Disease Journal, 24, 747-749.
4. Brouwers, P., Moss, H., Wolters, P., Eddy, J., Balis, F., Poplack, D.G., et al. (1990). Effect of continuousinfusion zidovudine therapy on neuropsychologic functioning in children with symptomatic human immunodeficiency virus infection. Journal of Pediatrics, 117, 980-985.
5. Bussing, R., Halfon, N., Benjamin, B., & Wells, K.B. (1995). Prevalence of behavior problems in US children with asthma. Archives of Pediatrics & Adolescent Medicine, 149, 565-572.
6. Byrne, M.W., & Honig, J. (2006). Health-related quality of life of HIV-infected children on complex antiretroviral therapy at home. Journal of the Association of Nurses in AIDS Care, 17, 27-35.
7. De Martino, M., Tovo, P.A., Balducci, M., Galli, L., Gabiano, C., Rezza, G., et al. (2000). Reduction in mortality with availability of antiretroviral therapy for children with perinatal HIV-1 infection. Italian register for HIV infection in children and the Italian national AIDS registry. JAMA, 284, 190-197.
8. Donenberg, G.R., & Pao, M. (2005). Youths and HIV/ AIDS: Psychiatry's role in a changing epidemic. Journal of the American Academy of Child and Adolescent Psychiatry, 44, 728-747.
9. Drotar, D. (2004). Measuring child health: Scientific questions, challenges, and recommendations. Ambulatory Pediatrics, 4, 353-357.
10. Eiser, C., & Morse, R. (2001). Can parents rate their child's health-related quality of life? Results of a systematic review. Quality of Life Research, 10, 347-357.
11. Foster, C.J., Biggs, R.L., Melvin, D., Walters, M.D., Tudor-Williams, G., & Lyall, E.G. (2006). Neurodevelopmental outcomes in children with HIV infection under 3 years of age. Developmental Medicine and Child Neurology, 48, 677-682.
12. Gortmaker, S.L., Hughes, M., Cervia, J., Brady, M., Johnson, G.M., Seage III, G.R., et al. (2001). Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1. New England Journal of Medicine, 345, 1522-1528.
13. Gortmaker, S.L., Lenderking, W.R., Clark, C., Lee, S., Fowler, M.G., & Oleske, J. (1998). Development and use of a pediatric quality of life questionnaire in AIDS clinical trials: Reliability and validity of the general health assessment for children. In D. Drotar (Ed.), Assessing pediatric health-related quality of life and functional status: Implications for research, practice, and policy (pp. 219-235). Mahwah, NJ: Laurence Erlbaum.
14. Gortmaker, S.L., Walker, D.K., Weitzman, M., & Sobol, A.M. (1990). Chronic conditions, socioeconomic risks, and behavioral problems in children and adolescents. Pediatrics, 85, 267-276.
15. Hollingshead, A.B. (1975). Four factor index of social status. New Haven, CT: Yale University.
16. McCoig, C., Castrejon, M.M., Castano, E., De Suman, O., Baez, C., Redondo, W., et al. (2002). Effect of combination antiretroviral therapy on cerebrospinal fluid HIV RNA, HIV resistance, and clinical manifestations of encephalopathy. Journal of Pediatrics, 141, 36-44.
17. Nacinovich, R., Galli, J., Bomba, M., Filippini, E., Parrinello, G., Nuzzo, M., et al. (2008). Neuropsychological development of children born to patients with antiphospholipid syndrome. Arthritis & Rheumatism, 59, 345-351.
18. R Development Core Team (2008). R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing [Computer software].
19. Sharland, M., Blanche, S., Castelli, G., Ramos, J., & Gibb, D.M. (2004). PENTAguidelines for the use of antiretroviral therapy, 2004. HIV Medicine, 5(Suppl. 2), 61-86.
20. Shiner, R.L., Masten, A.S., & Tellegen, A. (2002). Adevelopmental perspective on personality in emerging adulthood: Childhood antecedents and concurrent adaptation. Journal of Personality and Social Psychology, 83, 1165-1177.
21. Storm, D.S., Boland, M.G., Gortmaker, S.L., He, Y., Skurnick, J., Howland, L., et al. (2005). Protease inhibitor combination therapy, severity of illness, and quality of life among children with perinatally acquired HIV-1 infection. Pediatrics, 115, e173-e182.
22. Tepper, V.J., Farley, J.J., Rothman, M.I., Houck, D.L., Davis, K.F., Collins-Jones, T.L., et al. (1998). Neurodevelopmental/ neuroradiologic recovery of a child infected with HIV after treatment with combination antiretroviral therapy using the HIV-specific protease inhibitor ritonavir. Pediatrics, 101, E7.
23. Upton, P., Eiser, C., Cheung, I., Hutchings, H.A., Jenney, M., Maddocks, A., et al. (2005). Measurement properties of the UK-English version of the Pediatric Quality of Life Inventory 4.0 (PedsQL) generic core scales. Health and Quality of Life Outcomes, 3, 2-22.
24. Vandamme, A.M., Sonnerborg, A., Ait-Khaled, M., Albert, J., Asjo, B., Bacheler, L., et al. (2004). Updated European recommendations for the clinical use of HIV drug resistance testing. Antiviral Therapy, 9, 829-848.
25. Varni, J.W., Seid, M., & Kurtin, P.S. (2001). PedsQL 4.0: Reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations. Medical Care, 39, 800-812.
26. Verweel, G., van Rossum, A.M., Hartwig, N.G., Wolfs, T.F., Scherpbier, H.J., & De Groot, R. (2002). Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth. Pediatrics, 109, E25.